Biotech Values

[oldberkeley]

Re Arna: No position, ever, just got interested in it as an example of investor psychology.

When the advisory panel said no, I assumed most holders would move on, but the blind furor and desperate hope has been amazing. Now that the CRL is out, one might think that supporters would call it a day. Surprise! An astounding amount of posters on various boards are viewing this as a tremendous victory portending a stupendous share price increase in weeks to come.

It's true, we see what we want to see.